(Q34710504)

English

Focus on breast cancer

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

1 reference

Europe PubMed Central

Focus on breast cancer (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

1 reference

based on heuristic

inferred from title

1

object named as

Jose Baselga

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

object named as

Larry Norton

2

0 references

publication date

1 May 2002

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

319-322

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Pharmacodynamic studies of the epidermal growth factor receptor inhibitor ZD1839 in skin from cancer patients: histopathologic and molecular consequences of receptor inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900066-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I studies of anti-epidermal growth factor receptor chimeric antibody C225 alone and in combination with cisplatin.

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900066-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical trial with escalating doses of the antiepidermal growth factor receptor humanized monoclonal antibody EMD 72 000 in patients with advanced squamous cell carcinoma of the larynx and hypopharynx

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900066-1

7 January 2021

based on heuristic

inferred from DOI database lookup

The Effect of Raloxifene on Risk of Breast Cancer in Postmenopausal Women

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900066-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Positron emission tomography scanning: current and future applications

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900066-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900066-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Prophylactic surgery in women with a hereditary predisposition to breast and ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900066-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900066-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Mechanism-based target identification and drug discovery in cancer research

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900066-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Annual report to the nation on the status of cancer (1973 through 1998), featuring cancers with recent increasing trends

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900066-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Functional genomics and the breast cancer problem

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900066-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of screening mammography among women aged 40 to 49 years and 50 to 69 years: comparison of relative and absolute benefit

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900066-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Discovery of a novel Raf kinase inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900066-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Anastrozole is superior to tamoxifen as first-line therapy for advanced breast cancer in postmenopausal women: results of a North American multicenter randomized trial. Arimidex Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900066-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Breast cancer genetics: what we know and what we need

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900066-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Theoretical concepts and the emerging role of taxanes in adjuvant therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900066-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Cochrane review on screening for breast cancer with mammography.

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900066-1

7 January 2021

based on heuristic

inferred from DOI database lookup

UK and USA breast cancer deaths down 25% in year 2000 at ages 20-69 years.

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900066-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Ethnic differences in post-menopausal plasma oestrogen levels: high oestrone levels in Japanese-American women despite low weight

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900066-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Small molecule modulators of cyclin-dependent kinases for cancer therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900066-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900066-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Magnetic resonance imaging and mammography in women with a hereditary risk of breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900066-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Gene expression profiling predicts clinical outcome of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900066-1

7 January 2021

based on heuristic

inferred from DOI database lookup

mTOR, a novel target in breast cancer: the effect of CCI-779, an mTOR inhibitor, in preclinical models of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1535-6108%2802%2900066-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1535-6108(02)00066-1

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34710504&oldid=1966917777"